Parkinson’s Institute and Clinical Center is pleased to announce the appointment of Dr. Anthony Santiago as its new Chief Medical Officer. Dr. Santiago is among the nation’s top neurologists and Movement Disorders Specialists, and he is a dynamic leader who will grow our world-class multidisciplinary clinic.

Dr. Santiago has spent his career focused on making a meaningful impact for people affected by Parkinson’s. He will join our doctors in the clinic and begin seeing patients shortly. Additionally, Dr. Santiago is already recruiting the nation’s top Movement Disorder Specialists to join the team at the Parkinson’s Institute and Clinical Center.

We are excited about our collaboration with UCB, developers of Neupro® (rotigiotine transdermal system), a 24 hour time release patch which provides people with Parkinson’s continuous and stable delivery of their medication. UCB is working with us on our Parkinson’s Insight project to advance the understanding of medications used to treat Parkinson’s outside of a controlled clinical setting. Ideally, this study will help us deliver optimal healthcare for people living with Parkinson’s.

Parkinson’s Institute and Clinical Center Excited to Partner with CENTOGENE

The Parkinson’s Institute and Clinical Center and CENTOGENE have entered into a collaboration aimed at genetic screening of a large cohort of Parkinson’s patients in the US. Now, individual patients will be screened using a large customized panel carefully selected to identify pathophysiological relevant genetic variants for the development and treatment of Parkinson’s disease. For more information click here